Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 1 Treat to target, remission and low disease activity in SLE

Published byElfrieda Freeman Modified over 5 years ago

Similar presentations

Presentation on theme: "Figure 1 Treat to target, remission and low disease activity in SLE"— Presentation transcript:

1 Figure 1 Treat to target, remission and low disease activity in SLE
Figure 1 | Treat to target, remission and low disease activity in SLE. Control of active disease in systemic lupus erythematosus (SLE) can be conceived as concentric circles of progressively improving treatment response states associated with stepwise improvements in outcome, representing a continuum along which treatment can be directed. Rates of damage accrual will be lower at each stage of disease control, theoretically reaching zero for complete off-treatment remission. LLDAS, lupus low disease activity state. Morand, E. F. (2016) Remission in SLE — are we there yet? Nat. Rev. Rheumatol. doi: /nrrheum

Download ppt "Figure 1 Treat to target, remission and low disease activity in SLE"

Similar presentations

The Patient Experience With Systemic Lupus Erythematosus

The Patient Experience With Systemic Lupus Erythematosus
Systemic Lupus Erythematosus

Systemic Lupus Erythematosus
Figure 3 The induction of anti-DNA antibodies by bacterial DNA

Figure 3 The induction of anti-DNA antibodies by bacterial DNA
Figure 1 Lymphocytes during the disease

Figure 1 Lymphocytes during the disease
of different experimental arthritis models

of different experimental arthritis models
Figure 3 Connexins in cartilage

Figure 3 Connexins in cartilage
Figure 5 Involvement of B cells in SLE

Figure 5 Involvement of B cells in SLE
Figure 4 The theoretical contribution of genetic and

Figure 4 The theoretical contribution of genetic and
Figure 1 Historical evolution of the clinical classification and

Figure 1 Historical evolution of the clinical classification and
Figure 2 A timeline summarizing the development of diagnostic tools in rheumatology Figure 2 | A timeline summarizing the development of diagnostic tools.

Figure 2 A timeline summarizing the development of diagnostic tools in rheumatology Figure 2 | A timeline summarizing the development of diagnostic tools.
Figure 1 Rheumatoid arthritis development over time in relation to the level of inflammation Figure 1 | Rheumatoid arthritis development over time in relation.

Figure 1 Rheumatoid arthritis development over time in relation to the level of inflammation Figure 1 | Rheumatoid arthritis development over time in relation.
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum
Figure 1 Induction of immune tolerance

Figure 1 Induction of immune tolerance
Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum
Figure 2 Heat map of targeted therapies in autoimmune diseases

Figure 2 Heat map of targeted therapies in autoimmune diseases
Figure 1 Organs involved in coeliac-disease-associated autoimmunity

Figure 1 Organs involved in coeliac-disease-associated autoimmunity
Figure 2 Targeted versus untargeted metabolomics approaches

Figure 2 Targeted versus untargeted metabolomics approaches
Figure 1 Metabolic profiling as a tool for studying rheumatic diseases

Figure 1 Metabolic profiling as a tool for studying rheumatic diseases
Figure 1 Schematic comparison of expected

Figure 1 Schematic comparison of expected

Similar presentations

Ads by Google